Skip to content
Screener

Atea Pharmaceuticals, Inc. AVIR Q1 2026 earnings

Reported May 12, 2026 · After market close

EPS-$0.57Beat by $0.03
Revenue estimate$22.4M
EPS estimate-$0.60

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$50.4M
EPS estimate-$0.51

FAQ

When did Atea Pharmaceuticals, Inc. report Q1 2026 earnings?
Atea Pharmaceuticals, Inc. (AVIR) reported Q1 2026 earnings on May 12, 2026 after market close.
What were Atea Pharmaceuticals, Inc.'s Q1 2026 revenue and EPS?
Atea Pharmaceuticals, Inc. reported eps of $-0.57 for Q1 2026.
Did Atea Pharmaceuticals, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.60 by $0.03.
How did Atea Pharmaceuticals, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 42.5% from $-0.40.
Where can I find Atea Pharmaceuticals, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-219507) and the 10-Q periodic report (0001193125-26-219678) directly on SEC EDGAR. The filing index links above go to sec.gov.